Merck & Co.'s expenditure on research and development from 2006 to 2023 (in million U.S. dollars)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Merck & Co.
Global positioning
5
- Premium Statistic Pharmaceutical market: worldwide revenue 2001-2023
- Premium Statistic Top global pharmaceutical companies based on pharma revenue 2022
- Premium Statistic Top 10 biotech and pharmaceutical companies based on market cap 2024
- Basic Statistic Projected top pharmaceutical companies based on sales 2023
- Basic Statistic Top drugs based on projected 2024 global sales
Key company data
5
Segments and products
5
- Premium Statistic Pharmaceutical revenue of Merck & Co by therapy class 2023
- Premium Statistic Merck & Co. - revenues by region 2019-2023
- Premium Statistic Merck & Co.'s top-selling drugs 2023
- Premium Statistic Merck & Co.'s Keytruda revenue 2014-2023
- Premium Statistic Sales forecast of top selling drugs worldwide 2028
Competitors
5
Research and development
5
- Premium Statistic Total global pharmaceutical R&D spending 2014-2028
- Premium Statistic R&D spending share of top pharmaceutical companies 2022
- Premium Statistic Merck & Co - expenditure on research and development 2006-2023
- Premium Statistic Top pharma companies worldwide 2024, by size of R&D pipeline
- Basic Statistic AI readiness of big pharma companies 2023
Further related statistics
19
- Merck & Co. - number of stockholders 2009-2019
- Merck & Co cash dividends per share declared 2009-2023
- Merck & Co number common outstanding shares 2009-2023
- Merck & Co cash dividends declared 2006-2023
- Merck & Co. - costs of materials and production 2009-2017
- Merck & Co. - costs of marketing and administration 2009-2017
- Merck & Co SG&A expenses 2014-2023
- Forecast of EBITDA of Merck & Co 2021-2022
- Orphan vs. non-orphan drugs median cost per patient per year 2014-2018
- Average peak sales forecast per new biopharmaceutical asset 2013-2023
- Average number of outstanding shares of Sanofi 2009-2023
- Boehringer Ingelheim's R&D expenditure as a percentage of revenue 2004-2023
- Bristol-Myers Squibb's EBIT 2015-2023
- Bristol-Myers Squibb's employee number 2015-2023
- Hungary: number of pharmaceutical preparations manufacturers 2013-2022
- China's Shanghai Pharmaceuticals sales volume 2021, by product
- Total value of healthcare financing deals in the U.S. in Q4 2020, by top states
- Revenue of Intellia Therapeutics 2015-2023
- Merck KGaA's revenue 1999-2023
Further Content: You might find this interesting as well
Statistics
- Merck & Co. - number of stockholders 2009-2019
- Merck & Co cash dividends per share declared 2009-2023
- Merck & Co number common outstanding shares 2009-2023
- Merck & Co cash dividends declared 2006-2023
- Merck & Co. - costs of materials and production 2009-2017
- Merck & Co. - costs of marketing and administration 2009-2017
- Merck & Co SG&A expenses 2014-2023
- Forecast of EBITDA of Merck & Co 2021-2022
- Orphan vs. non-orphan drugs median cost per patient per year 2014-2018
- Average peak sales forecast per new biopharmaceutical asset 2013-2023
- Average number of outstanding shares of Sanofi 2009-2023
- Boehringer Ingelheim's R&D expenditure as a percentage of revenue 2004-2023
- Bristol-Myers Squibb's EBIT 2015-2023
- Bristol-Myers Squibb's employee number 2015-2023
- Hungary: number of pharmaceutical preparations manufacturers 2013-2022
- China's Shanghai Pharmaceuticals sales volume 2021, by product
- Total value of healthcare financing deals in the U.S. in Q4 2020, by top states
- Revenue of Intellia Therapeutics 2015-2023
- Merck KGaA's revenue 1999-2023
Merck & Co.. (February 26, 2024). Merck & Co.'s expenditure on research and development from 2006 to 2023 (in million U.S. dollars) [Graph]. In Statista. Retrieved June 15, 2024, from https://www.statista.com/statistics/282738/expenditure-on-research-and-development-by-merck-and-co/
Merck & Co.. "Merck & Co.'s expenditure on research and development from 2006 to 2023 (in million U.S. dollars)." Chart. February 26, 2024. Statista. Accessed June 15, 2024. https://www.statista.com/statistics/282738/expenditure-on-research-and-development-by-merck-and-co/
Merck & Co.. (2024). Merck & Co.'s expenditure on research and development from 2006 to 2023 (in million U.S. dollars). Statista. Statista Inc.. Accessed: June 15, 2024. https://www.statista.com/statistics/282738/expenditure-on-research-and-development-by-merck-and-co/
Merck & Co.. "Merck & Co.'s Expenditure on Research and Development from 2006 to 2023 (in Million U.S. Dollars)." Statista, Statista Inc., 26 Feb 2024, https://www.statista.com/statistics/282738/expenditure-on-research-and-development-by-merck-and-co/
Merck & Co., Merck & Co.'s expenditure on research and development from 2006 to 2023 (in million U.S. dollars) Statista, https://www.statista.com/statistics/282738/expenditure-on-research-and-development-by-merck-and-co/ (last visited June 15, 2024)
Merck & Co.'s expenditure on research and development from 2006 to 2023 (in million U.S. dollars) [Graph], Merck & Co., February 26, 2024. [Online]. Available: https://www.statista.com/statistics/282738/expenditure-on-research-and-development-by-merck-and-co/